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Introduction: Specific ligand immobilisation can enhance endothelial
cells (ECs) adhesion on stent surface, avoiding migration of smooth
muscle cells (SMCs) [1]. Wei et al. [2] demonstrated that the REDV
peptide promote the EC growth respect to SMCs. In this work, poly-
meric substrates were coated through layer-by-layer technique to func-
tionalize the final layer with the CRETTAWAC sequence able to favor
ECs and inhibit platelet attachment [3].
Materials and methods: Aminolysed poly(L-lactide)/poly(DL-lac-
tide-co-glycolide) (PLLA/PLGA) films were dipped into alternate aque-
ous solutions (0.5% w/v, pH: 4.5) of poly(sodium 4-styrene sulfonate)
(PSS) and poly(diallyldimethylammonium chloride) (PDDA) for
15 minutes each, with intermediate washing steps in bidistilled water
(pH: 4.5) for 5 minutes. Heparin (HE) was deposited as the last layer
of the coating. Surface composition was evaluated through XPS analysis
and via colorimetric method. The CRETTAWAC effect on re-endothelial-
ization was evaluated using human umbilical vein endothelial cells
(HUVECs). Cells were seeded onto three different surface: CRETTA-
WAC, bovine serum albumin (BSA) and fibronectin (FN).
Results: The deposition of multilayer coating was confirmed by XPS
analysis.
Table 1. Atomic percentage of chemical elements of functionalised sam-
ples.
C1s O1s N1s S2p
Aminolyzed PLLA/PLGA 64.0 35.3 0.7 –
PLLA/PLGA + 14L 71.2 26.0 1.3 1.5
PLLA/PLGA + 15L 70.2 25.8 2.2 1.8
After the deposition of 14 and 15 polyelectrolyte layers the percent-
age of N and S was higher respect to aminolysed PLLA/PLGA due to
the deposition of PDDA, PSS and HE (Table 1). In vitro tests show that
after 2 hours the number of adhered cells on CRETTAWAC functiona-
lised substrate were less respect to FN. After 4 hours HUVECs seeded
on CRETTAWAC showed a spread shape.
Discussion and conclusions: Through the LbL technique allows to obtain
functional coatings without changing the bulk properties. CRETTAWAC
sequence was shown to bind the a5b1 integrin that is present on the
surface of ECs but lacking on platelets. LBL could be exploited for sur-
face functionalisation with KKKKKKSGSSGKCRRETAWAC, able to elec-
trostatically interact with HE.
Acknowledgments: NANOSTENT (Regional Project, Regione Pie-
monte).
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Introduction: The fabrication of bioactive scaffolds able to mimic the
in vivo cellular microenvironment represents a challenge for tissue
engineering (TE). In the present work, we propose the combination
of electrospinning (ESP) and soft-molecular imprinting (soft-MI) [1]
to create a soft-molecular imprinted fibrous scaffold for TE applica-
tions. By combining these techniques, we fabricated poly-L-lactide
acid (PLLA), PolyActive (PA) and poly lactic-co-glycolic acid (PLGA)
based scaffolds functionalized using different protein arranged onto
the surface.
Materials and methods: A functionalized PDMS mold was used as a tar-
get for the ESP jet. The PDMS mold was prepared using a commercial
product (Sylgard 184 kit, Dow Corning, MI) with a 10:1 (w/w) ratio.
The mixture was casted onto a silica wafer comprising different cus-
tom-made geometries, degassed, and finally cured in an oven for
4 hours at 70°C. To reduce the hydrophobicity of its surface, the PDMS
mold was treated with Piranha Solution (3:1). After the derivatization
of its surface with a 1% solution of (3-Aminopropyl)-trimethoxysilane
in Toluene, the PDMS mold was activated with an EDC-NHS solution.
Finally, the mold was immersed in a protein solution for 24 hours. The
proteins used as templates were FITC-albumin and TRITC-lectin. Three
different polymer solutions were prepared: PLGA 4% (w/v) in
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), PLDLA 5% (w/v) in HFIP
and PA300 20% (w/v) in CHCl3/HFIP 70:30 (v/v). The functionalized
PDMS mold was positioned under the ESP jet and the ESP fibers fabri-
cated at a flow rate of 1 mL/h and a voltage of 20 kV. The imprinted
scaffolds were tested for their ability to rebind the template protein and
observed with a fluorescence microscope. To evaluate the selectivity for
a particular template molecule, the imprinted scaffolds were immersed
in a solution of both FITC-albumin and TRITC-lectin. The obtained
scaffolds were analyzed by fluorescence microscopy to ensure that no
weakly bound protein on the PDMS was transferred to them.
Figure 1. Microscopy images of adhered HUVECs on different func-
tionalised surface after 4 hours.
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Results: The imprinted scaffolds demonstrated affinity and selectivity
for their template molecule over the other fluorescent protein competi-
tor. Specifically, the FITC-albumin imprinted scaffolds showed protein
absorption in a solution of FITC-albumin (Fig. 1a) while no protein
adsorption was seen in a solution of TRITC-lectin. Similar results were
obtained with the TRITC-lectin imprinted scaffolds (Fig. 1b).
Figure 1. (a) FITC-albumin imprinted PLGA scaffold; (b) TRITC-lectin
imprinted PLGA scaffold.
Discussion and conclusions: The integration of ESP and soft-MI repre-
sents a promising technique for the realization of scaffolds for TE appli-
cations, because it allow us to mimic the biological environments
through the selective bindings of specific endogenous proteins.
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Introduction: As an interdisciplinary field Tissue Engineering is aiming
at the reproducibility of damaged tissue or organs. Although there are
constantly achieved successes in the design of tissue engineered con-
structions, there is still the difficulty to provide those with a sufficient
vascularization. Successful applications in Tissue Engineering involve
thin avascular tissue like cartilage and skin without a vasculature.
Aim of the present research work is the production of electrospun mi-
croyarns to support angiogenesis in fibrin gel scaffolds.
Materials and methods: Microyarns with different morphological prop-
erties (polymer concentration, polymer blend, diameter, torsion angle)
were produced by electrospinning[1]. Polylactide (PLA) and polyethyl-
ene glycol (PEG) were used as polymers. The electrospun microyarns
were UV- sterilized for 30 minutes under the laminar flow hood. After
sterilization the microyarns were seeded with 1.4 9 106 human umbili-
cal vein endothelial cells (HUVECs) and incubated (37°C, 5%CO2) in
24-well plates for 24 hours. Subsequently the microyarns were stained
with 40,6-Diamidin-2-phenylindol (DAPI) and analyzed under the fluo-
rescence microsope[2]. Those of the microyarns that showed the best
proliferations were used for further experiments. To proof their capabil-
ity of developing capillary-like structures, the microyarns were culti-
vated in 3D. The micoyarns were first seeded in 24 well plates with
HUVECs; then embedded in fibrin gel containing both HUVECs and
human dermal foreskin fibroblasts (HDFFs). After 14 days of co-culti-
vation the fibrin gels were fixed and immunostained (CD31). Verifica-
tion and quantification of the capillary-like structures were
implemented by two-photon laser scanning microscopy (TPLSM) and
ImagePro Analyzer software. All experiments were replicated three
times with different donors.
Results: After 14 days of co-cultivation, it could be observed that there
is formation of capillary-like structures within the HUVEC/HDFF co-cul-
ture system. There were also significant distinctions in formation
between the different morphological properties of the microyarns.
Figure 1. Cell adhesion on PLA/PEG microyarn (l), SEM image of PLA/
PEG microyarn (r).
Discussion and conclusions: The present work shows, that microyarns
can be applied as textile scaffolds for vascularization. Depending on
their morphological property, they are also capable to influence the ori-
entation of cell adhesion.
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Introduction: Guided bone regeneration (GBR) is employed in dental
implantology and the treatment of periodontal bone loss. It is based on
the surgical placement of a barrier membrane that excludes soft tissue
growth that would otherwise prevent bone healing [1-2].Unfortunately,
non-resorbable membranes require a second operation for their
removal while resorbable collagen membranes have an associated risk
of disease transmission, and also existing commercial systems do not
promote tissue regeneration beyond their barrier function. The aim was
therefore to develop a functionalised, bilayered resorbable membrane
with a dense layer to contact soft tissues, and a porous layer to promote
bone healing.
Materials and methods: Compact films of poly(D,L-lactide-co-glyco-
lide) (PLGA, 75:25) were prepared by solvent casting from acetone.
Porous membranes were prepared by dissolving PLGA (22% w/v)
and nano-hydroxyapatite powder (20% w/w) [3] in acetone prior to
electrospinning. Both layers were subjected to plasma polymerisation
for acrylic acid grafting, and were modified by layer-by-layer (LbL)
technique to generate functional polyelectrolyte (poly (styrene sulfo-
nate) /poly(allyl amine) (PSS/ PAH); Sigma) to obtain 20 nanolayers
to incorporate (1) an antibiotic drug (Metronidazole; Sigma) to pro-
vide antibacterial activity for the compact layer, and (2) specific bone
matrix peptides (KRSR and FHRRIKA; GenScript) to promote bone
healing at the porous surface. The layers were assembled using fibrin
glue. Drug release from the compact layer was evaluated by UV-Vis,
while in vitro biocompatibility was investigated using L292 mouse fi-
broblasts (compact layer) and rat mesenchymal stromal cells (porous
layer).
Results and discussion: FTIR-ATR showed that the typical absorption
bands of PAH and PSS increased with layer number (i.e. SO3
stretching vibrations at 1130/cm for PSS, and NH scissoring vibra-
tions at 1580/cm for PAH). The contact angle values had an alter-
nate behaviour from the 9th and from 11th nanolayer for the
compact and porous layer respectively. XPS spectra showed a N1s
peak at 399.5 eV and S2p peak at 168 eV, indicating PAH and PSS
had been introduced (Fig. 1).
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